REFERENCES
- Inoue , L. Y. T. , Thall , P. F. , and Berry , D. A. ( 2002 ). Seamlessly Expanding a Randomized Phase II Trial to Phase III , Biometrics 58 : 823 – 831 .
- Kelly , P. J. , Stallard , N. , and Todd , S. ( 2005 ). An Adaptive Group Sequential Design for Phase II/III Clinical Trials that Involve Treatment Selection , Journal of Biopharmaceutical Statistics 15 : 641 – 658 .
- Schaid , D. J. , Ingle , J. N. , Wieand , S. , and Ahmann , D. L. ( 1988 ). A Design for Phase II Testing of Anticancer Agents Within a Phase III Clinical Trial , Controlled Clinical Trials 9 : 107 – 118 .
- Schaid , D. J. , Wieand , H. S. , and Therneau , T. M. ( 1990 ). Optimal Two-Stage Screening Designs for Survival Comparisons , Biometrika 77 : 507 – 513 .
- Simon , R. , Wittes , R. E. , and Ellenberg , S. S. ( 1985 ). Randomized Phase II Clinical Trials , Cancer Treatment Reports 69 : 1375 – 1381 .
- Stallard , N. and Todd , S. ( 2003 ). Sequential Designs for Phase III Clinical Trials Incorporating Treatment Selection , Statistics in Medicine 22 : 689 – 703 .
- Thall , P. F. ( 2008 ). A Review of Phase 2–3 Clinical Trial Designs , Lifetime Data Analysis 14 : 37 – 53 .
- Thall , P. F. , Simon , R. , and Ellenberg , S. S. ( 1988 ). Two-Stage Selection and Testing Designs for Comparative Clinical Trials , Biometrika 75 : 303 – 310 .
- Thall , P. F. , Lee , J. J. , Tseng , C.-H. , and Estey , E. H. ( 1999 ). Accrual Strategies for Phase I Trials with Delayed Patient Outcome , Statistics in Medicine 18 : 1155 – 1169 .
- Todd , S. and Stallard , N. ( 2005 ). A New Clinical Trial Design Combining Phases II and III: Sequential Designs with Treatment Selection and a Change of Endpoint , Drug Information Journal 39 : 109 – 118 .
- Recommended by Nitis Mukhopadhyay